Alabama

The Board of Pharmacy and the Board of Medical Examiners held a Joint Committee meeting to discuss the issue of test and treat in community pharmacies. Both Boards have made the decision to begin the rulemaking process to amend our rule to allow for test and treat under certain conditions. To learn more about what conditions must be met before beginning test and treat, you can view the drafted language on the Board of Pharmacy’s website (under “Resources;” select “Statutes & Rules) once stamped by LSA (Legislative Services Agency). You can see all of the rules the Board is working on by clicking here. If you do not see a draft available, it has not been stamped by LSA yet.  
 
Also in Alabama, emergency rule 680-X-2-.49.01ER Remote Work by Pharmacists is currently in place until October 29, 2023. The permanent rule is currently in the rulemaking process. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2023-08-18T12:13:38-04:00August 18, 2023|Alabama|

Arizona

The Board of Pharmacy posted a notice announcing [t]he online renewal cycle will begin on September 5, 2023, at 00:01 MST and end on November 1, 2023, at 23:59 MST. Renewals submitted after November 1, 2023, are subject to a late renewal penalty. You may renew it by logging into your online profile. Please note: A person shall not apply for a license renewal more than sixty days before the expiration date of the license.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-08-18T12:13:06-04:00August 18, 2023|Arizona|

California

The Department of Health Care Services (DHCS) posted the following bulletins, notices, and alerts on the Medi-Cal Rx Web Portal. Please note the update on Pharmacy Retroactive Claim Adjustments in August 2023. 

Also in California, Medi-Cal posted the following. Please note the update on Pharmacy Retroactive Claim Adjustments in August 2023.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-08-18T12:12:37-04:00August 18, 2023|California|

Colorado

The Department of Regulatory Agencies (DORA) will hold a stakeholder webinar at 1:00 p.m. MT on August 21 to discuss several proposed rules, including: 

  • Rule 23.00.70 – ELECTRONIC PRESCRIPTION MONITORING PROGRAM – Release of PDMP (Prescription Drug Monitoring Program). Information – The purpose of the proposed amendments to Board Rule 23 is to reflect feedback from several stakeholders and board members to clarify records requests for deceased individuals. 
  • Rule 3, 11, 17, 20, and 21 – DISPENSING, RECORDS AND RECORDKEEPING, COLLABORATIVE PHARMACY PRACTICE, CENTRAL PRESCRIPTION PROCESSING, and COMPOUNDING – The purpose of the proposed amendments to Board Rule 3, 11, 17, 20, and 21 are to reflect feedback from several stakeholders and board members to bring our rules up to date with digital technology and other outlet protocols and other recordkeeping means through digital formats. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-08-18T12:11:47-04:00August 18, 2023|Colorado|

Connecticut

During this year’s legislation session, Connecticut Public Act 23-19 was passed, and pharmacists are now allowed to vaccinate children ages 12 years and up. Regulations are expected to be adopted by the Department of Consumer Protection, in consultation with the Commissioner of Public Health and the Commission of Pharmacy. While regulations and legal questions are worked through, the Department of Public Health (DPH) Immunization Program would like to assist you with enrollment in the Connecticut (Pediatric) Vaccine Program (CVP). Per CGS Sec. 19a-7f, all vaccines administered to children in Connecticut available through the CVP must be procured through the Immunization Program.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-08-18T12:11:21-04:00August 18, 2023|Connecticut|

Hawaii

2023-08-18T12:10:50-04:00August 18, 2023|Hawaii|

Illinois

HB 3203, legislation that authorizes pharmacists or retailers to sell fentanyl test strips over the counter and authorizes county health departments to distribute fentanyl test strings at their facilities for no fee was signed by Gov. JB Pritzker (D) on August 4th and goes into effect January 1, 2024.  

Also signed by Gov. Pritzker (D) on August 4th was HB 3631, legislation that prohibits a pharmacy benefit manager (PBM) from retaliating against a pharmacist or pharmacy for disclosing information in a court, administrative hearing, before a legislative commission or committee, or any proceeding, if the pharmacist or pharmacy has reasonable cause to believe that the disclosed information is evidence of a violation of state or federal law, rule or regulation. The bill also prohibits a PBM from retaliating against a pharmacist or pharmacy for disclosing information to a government or law enforcement agency, if the pharmacist or pharmacy has reasonable cause to believe that the disclosed information is evidence of a violation of state or federal law, rule, or regulation. A pharmacist or pharmacy must make reasonable efforts to limit the disclosure of confidential and proprietary information. This measure went into effect July 1, 2023.  

Also in Illinois, the Illinois Department of Healthcare and Family Services (HFS) has issued notice that implements Public Act 102-1051 which allows pharmacists to be reimbursed for human immunodeficiency virus (HIV) pre- and post-exposure prophylaxis assessment and consultation. This new policy is effective with dates of service on and after January 1, 2023, and applies to the Medicaid fee-for-service (FFS) program and the HealthChoice Illinois (HCI) managed care organizations (MCOs). 

In accordance with the Act, the Department of Healthcare and Family Services (HFS) will cover patient care services provided by a pharmacist for HIV pre- and post-exposure prophylaxis assessment and consultation at 85% of the physician rate. Pharmacists must have a standing order with an associated physician, be licensed to practice medicine in all its branches and be enrolled in the Illinois Medical Assistance Program to perform the assessment and consultation services.  

HFS has also issued notice informing pharmacies that HFS has opened additional procedure codes that may be billed for pharmacists providing hormonal contraceptive assessment and consultation services. This applies to the Medicaid fee-for-service (FFS) program and the HealthChoice Illinois (HCI) managed care organization (MCO) plans. 

By provider notice dated October 31, 2022, the Department of Healthcare and Family Services (HFS) notified providers that patient care services provided by a pharmacist for hormonal contraceptive assessment and consultation would be covered at 85% of the physician rate. HFS identified CPT procedure code 99401 – Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes, for billing. Modifier FP must be billed in conjunction with procedure code 99401.  

Effective retroactive to August 1, 2022, pharmacies may bill on behalf of pharmacists for one of the following Evaluation and Management procedure codes with the FP modifier, in addition to 99401, for the assessment component of the family planning service. 

HFS has been notified of an extreme shortage of Cisplatin, which has been determined to constitute a medical emergency for those patients in need. In accordance with the actions by the Food and Drug Administration (FDA), a non-FDA approved Cisplatin, manufactured by Qilu Pharmaceutical Company in conjunction with Apotex Corporation, can be distributed into and within the State of Illinois and will be reimbursable for Illinois Medicaid enrolled providers. Additional information can be found here. 

Finally in Illinois, Snap EBT (Electronic Benefit Transfer) data theft has been on the rise in stores across the Country. The Department of Human Services (IDHS) has confirmed a recent surge in compromised cards in Illinois. Retailers are urged to immediately contact their POS (Point of Sale) vendor, local police, FNS and IDHS if skimming devices are discovered, or your pin pads have been compromised in any way. With prompt notification, IDHS can move to protect cardholders before their benefits are stolen. Tracking skimming after the theft is exceedingly difficult to do. Contact IDHS at: dhs.ebtretailer.reportfraud@illinois.gov  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2023-08-18T12:09:50-04:00August 18, 2023|Illinois|

Louisiana

Recognized by her peers from across the state as someone dedicated to the advancement of the profession of pharmacy, Jennifer Dupree, RPh with Walmart, was honored by NACDS at the Louisiana Pharmacists Association’s annual meeting as the 2023 Louisiana Chain Pharmacist of the Year 

Also in Louisiana, the Department of Health’s (LDH (Louisiana Department of Health)) 17-page August 2023 Provider Update is on Medicaid’s website.  

Also in Louisiana, here are two additional updates of interest to pharmacies. 

Also in Louisiana, the Board of Pharmacy summarized new laws adopted in 2023 which impact the practice of pharmacy or Board operations.  

Finally in Louisiana, the Board of Pharmacy quarterly Board meeting was held on August 16 at the Board office in Baton Rouge. The agenda and meeting materials are available here. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-08-18T12:09:05-04:00August 18, 2023|Louisiana|

Maine

The Maine legislative session just ended this week with two pharmacy bills left unfunded on the appropriations table, which means they will be reconsidered in the 2024 session. The two bills were LD 1558, a bill that would ban pharmacies from selling most tobacco products, and LD 275, a bill that would study the workplace treatment of pharmacists.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-08-18T12:08:09-04:00August 18, 2023|Maine|
Go to Top